Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Individual Level Prediction of Cognitive Decline in Alzheimer’s Disease

FY 2018-19

Summary
Alzheimer’s Disease (AD) is a devastating neurodegenerative disease with an immense burden on society. A 2017 estimate showed that AD affects over 5 million individuals in the U.S. alone and costs over $200 billions. While no cure has been found, early-detection of AD help with in early-intervention which improves the patients' quality of life and reduces the cost to society. For this reason, individual-level prediction of AD is essential. As it stands, current AD research has identified numerous group-level differences between AD and non-AD subjects, but no robust subject-level detection system is available. This is the problem I would like to solve. Specifically, I will be attempting to predict the decline in cognitive abilities experienced by patients suffering from AD, using machine learning methodologies. I will use unsupervised clustering to identify groups of patients who has similar cognitive trajectories across time (e.g. one group may maintain a high degree of cognitive abilities as they age, while another may show rapid decline). Importantly, I will be extending upon previous works done in the lab to include many different clinical rating scales to provide a nuanced measure of each individual’s cognitive ability. Then, I will borrow methods from supervised machine learning to predict which trajectory each subject belongs to, using data that can be collected in the clinic, such as demography, genetics and neuroanatomical structures. This work holds the promise of constructing a robust predictive algorithm which can help clinicians be more informed and make better clinical decisions with regard to the treatment of AD patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406565
Name
Chen Anthony G
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Individual Level Prediction of Cognitive Decline in Alzheimer’s Disease
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Artificial Intelligence; Brain Imaging; Disease Prediction; Machine Learning; Mental Illness
Abstract
Alzheimer’s Disease (AD) is a devastating neurodegenerative disease with an immense burden on society. A 2017 estimate showed that AD affects over 5 million individuals in the U.S. alone and costs over $200 billions. While no cure has been found, early-detection of AD help with in early-intervention which improves the patients' quality of life and reduces the cost to society. For this reason, individual-level prediction of AD is essential. As it stands, current AD research has identified numerous group-level differences between AD and non-AD subjects, but no robust subject-level detection system is available. This is the problem I would like to solve. Specifically, I will be attempting to predict the decline in cognitive abilities experienced by patients suffering from AD, using machine learning methodologies. I will use unsupervised clustering to identify groups of patients who has similar cognitive trajectories across time (e.g. one group may maintain a high degree of cognitive abilities as they age, while another may show rapid decline). Importantly, I will be extending upon previous works done in the lab to include many different clinical rating scales to provide a nuanced measure of each individual’s cognitive ability. Then, I will borrow methods from supervised machine learning to predict which trajectory each subject belongs to, using data that can be collected in the clinic, such as demography, genetics and neuroanatomical structures. This work holds the promise of constructing a robust predictive algorithm which can help clinicians be more informed and make better clinical decisions with regard to the treatment of AD patients.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chen, Anthony G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~